"Whole Genome Sequencing is the future gold standard in DST. It is comprehensive, accessible, afforda"...read more
A single test for simultaneous evaluation of all resistance markers, as well as the differentiation between mixed infection, relapse and reinfection










| Drug Analysis | Antibiotic Coverage | |
|---|---|---|
| ΩTB® | 18 antibiotics including bedaquiline and delamanid | |
| Culture Test | 13 - 15 antibiotics | |
| CBNAAT | 1 - 2 antibiotics | |
| LPA | Targeted for first line or second line |

DR profile of 18 drugs, Mixed infections and Co-infections incl NTM
Tested and validated on >10,000 genomes and >1000 clinical samples
High sensitivity and specificity comparable to molecular methods
Test cost less than or comparable to culture testing